The review assessed the effects of calcium-based versus non-calcium-based phosphate binders on mortality, cardiovascular events and vascular calcification in patients with chronic kidney disease. Although no significant differences were found, the results did not exclude an important beneficial effect of non-calcium-based phosphate binders. The authors' conclusions are appropriately conservative given the quality of the included studies.
Study selection
Randomised and non-randomised controlled trials that compared the effectiveness of calcium-based versus non calciumbased phosphate binders were eligible for inclusion. Outcome inclusion criteria were not specified. The primary outcome was defined as all-cause mortality in randomised controlled trials (RCTs). Secondary outcomes were mortality, cardiovascular events (fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, sudden death), fractures, vascular calcification and vascular compliance in patients with chronic kidney disease.
In the included studies, where stated, participants had a mean age of 47 to 60 years and 17% to 52% were female. All studies except one study included patients on haemodialysis (one included pre-dialysis patients). No patients were on peritoneal dialysis. Follow-up ranged from five to 24 months; one study had an extended follow-up in a subsample of participants to 44 months. The non-calcium phosphate binder in all studies was sevelamer. The calcium-based binders used were calcium acetate and calcium carbonate.
All five reviewers independently reviewed the results of the search according to predefined selection criteria; discrepancies were resolved by consensus.
Assessment of study quality
Two reviewers independently reviewed each study according to the Cochrane Risk of Bias tool to rate studies on the basis of the domains of sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, incomplete outcome data, selective outcome reporting and other sources of bias. The overall risk of bias for each study was rated as low (all domains low risk), unclear (unclear for at least one domain) or high (high for at least one domain). Discrepancies were resolved by consensus. The reviewers were not blind to the study authors, institution or journal of publication.
Data extraction
Relative risks, odds ratios and mean differences for intervention and control groups were extracted.
Two reviewers independently extracted the data; disagreements were resolved by consensus and discussion with a third reviewer.
